Biofrontera Pharmaceuticals Holding AG, DNAPrint deal

DNAG acquired an 18% stake in Biofrontera

Read the full 73 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE